Phenomix Sciences - About the company
Phenomix Sciences is a series A company based in Saint Paul (United States), founded in 2017 by Andres Acosta and Michael Camilleri. It operates as a Provider of test for personalized management of obesity. Phenomix Sciences has raised $10.2M in funding.
Company Details
Provider of test for personalized management of obesity. The company has developed a blood test that helps in weight loss management. It has used technology for using precision medicine for obesity treatment. The test assists with the diagnosis, medication, procedure selection, and more.
- Website
- www.phenomixsciences.com/
- Email ID
- *****@phenomixsciences.com
- Phone Number
- +1 **********
- Registered Address
- 1000 Westgate Drive, Suite 1002, St Paul, MN
Key Metrics
Founded Year
2017
Location
Saint Paul, United States
Stage
Series A
Total Funding
$10.2M in 7 rounds
Latest Funding Round
Ranked
1st among 2 active competitors
Employee Count
14 as on Sep 30, 2026
Similar Companies
Legal entities associated with Phenomix Sciences
Phenomix Sciences is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Phenomix Sciences LLC CIN: 0001757804 , United States, Active | Aug 09, 2017 | - | 2 (As on Dec 31, 2019) | - |
Phenomix Sciences LLC CIN: 822430180 , United States, Active | Nov 08, 2018 | - | - | - |
Sign up to download Phenomix Sciences' company profile
Phenomix Sciences's funding and investors
Phenomix Sciences has raised a total funding of $10.2M over 7 rounds. Its first funding round was on May 17, 2018. Phenomix Sciences has 6 institutional investors.
Here is the list of recent funding rounds of Phenomix Sciences:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 23, 2025 | 6727499 | Series A | 4380364 | 3914491 | 8026860 | 7561704 |
Feb 28, 2025 | 7492700 | Grant (prize money) | 7209408 | 2218668 | 4634577 | |
May 16, 2024 | 9449111 | Grant (prize money) | 8767452 | 9449841 | 4428807 |
View details of Phenomix Sciences's funding rounds and investors
Phenomix Sciences' founders and board of directors
Founder? Claim ProfileThe founders of Phenomix Sciences are Andres Acosta and Michael Camilleri.
Here are the details of Phenomix Sciences' key team members:
- Andres Acosta: Founder & CEO of Phenomix Sciences and founder of 1 other company. Contact Info: 1 email address
- Michael Camilleri: Co-Founder of Phenomix Sciences.
View details of Phenomix Sciences's Founder profiles and Board Members
Phenomix Sciences' employee count trend
Phenomix Sciences has 14 employees as of Sep 26. Here is Phenomix Sciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Phenomix Sciences's Competitors and alternates
Top competitors of Phenomix Sciences include TRU-1. Here is the list of Top 10 competitors of Phenomix Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Phenomix Sciences 2017, Saint Paul (United States), Series A | Provider of test for personalized management of obesity | $10.2M | 42/100 | |
2nd | ![]() TRU-1 2024, Los Angeles (United States), Unfunded | Provider of genetic testing kits for weight loss medication response | - | - | 16/100 |
Looking for more details on Phenomix Sciences's competitors? Click here to see the top ones
Phenomix Sciences's Investments and acquisitions
Phenomix Sciences has made no investments or acquisitions yet.
Reports related to Phenomix Sciences
Here is the latest report on Phenomix Sciences's sector:
News related to Phenomix Sciences
•
Phenomix Sciences Launches Clinical Trial to Predict GLP-1 ResponseHIT Consultant•Apr 08, 2025•Phenomix Sciences
•
Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity CareGlobeNewswire•Oct 17, 2024•Phenomix Sciences, InformedDNA
•
Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha PartnershipPR Newswire•Jul 09, 2024•Phenomix Sciences, Alpha
•
Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine AdoptionHIT Consultant•May 16, 2024•Phenomix Sciences, Dexcom, LabCorp, Health2047
•
Phenomix Sciences Launches 3-in-1 Obesity Phenotyping TestHIT Consultant•Apr 04, 2024•Phenomix Sciences
•
Mayo Clinic, Phenomix Awarded First Patent for Obesity PhenotypingHIT Consultant•Sep 29, 2023•Phenomix Sciences
•
Phenomix launches first of 4 obesity phenotype tests amid weight-loss drug boomFierce Biotech•Mar 31, 2023•Phenomix Sciences
•
Phenomix Sciences has filed a notice of an exempt offering of securities to raise $5,028,735.00 in New Equity Investment.intelligence360•Mar 03, 2023•Phenomix Sciences
•
Phenomix Sciences Launches Obesity Biobanking Registry Studying Personalized Treatment Options Based on GeneticsHIT Consultant•May 27, 2022•Phenomix Sciences
•
Phenomix Sciences taps Mayo Clinic tech for AI-powered obesity diagnosticFierce Biotech•May 05, 2021•Phenomix Sciences
Are you a Founder ?
FAQs about Phenomix Sciences
Explore our recently published companies
- Turn Key Franchises - United States based, Unfunded company
- Coa Solutions - Unfunded company
- Unipahal - Ahmedabad based, Unfunded company
- Alloc8Corp - Brampton based, 2017 founded, Unfunded company
- The24s - Gebze based, Unfunded company
- PWC Consultants - United States based, 1989 founded, Public company
